The following section deals with Pharmaceutical Ingredients used for manufacturing the medicinal products
Active Pharmaceutical Ingredients
On the sidelines of 22nd St. Petersburg International Economic Forum, Alexey Dyumin, the Governor of the Tula region, signed an agreement with Mikhail Shibaev, General Director of Efremov-Pharma LLC.
The report of Transparency Market Agency provides detailed qualitative analysis of the market dynamics that affect the growth of the global market.
On May 14, 2018, the expert council of St. Petersburg Special Economic Zone (SEZ) will review a business plan for building a plant to manufacture active pharmaceutical substances at Novoorlovskaya site.
Contract development and manufacturing organisation (CDMO) Ardena has acquired Syntagon, a leading contract manufacturer of novel active pharmaceutical ingredients (APIs) and excipients.
The new line was announced in November 2017 and enhances capacity at the site while complementing AMRI’s other aseptic API manufacturing plants in Bon Encontre and Tonneins, France.
Codexis and Porton Pharma Solutions announced a strategic collaboration to deploy Codexis’ world-leading biocatalyst technology within Porton’s global custom intermediate and API development and manufacturing business.